 Julius Turian
Concepts (164)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiotherapy Planning, Computer-Assisted | 16 | 2021 | 78 | 2.860 |
Why?
| | Radiotherapy Dosage | 17 | 2021 | 149 | 1.640 |
Why?
| | Brachytherapy | 7 | 2021 | 67 | 1.610 |
Why?
| | Radiotherapy, Intensity-Modulated | 7 | 2020 | 39 | 1.500 |
Why?
| | Head and Neck Neoplasms | 3 | 2017 | 137 | 1.220 |
Why?
| | Hippocampus | 5 | 2013 | 295 | 1.200 |
Why?
| | Brain Neoplasms | 6 | 2013 | 187 | 1.160 |
Why?
| | Radiometry | 8 | 2017 | 47 | 1.140 |
Why?
| | Cranial Irradiation | 4 | 2011 | 18 | 1.040 |
Why?
| | Radiation Injuries | 4 | 2011 | 44 | 1.010 |
Why?
| | Radiotherapy, Conformal | 5 | 2017 | 24 | 0.950 |
Why?
| | Glioma | 2 | 2013 | 58 | 0.900 |
Why?
| | Pluripotent Stem Cells | 2 | 2011 | 8 | 0.850 |
Why?
| | Employment | 1 | 2021 | 39 | 0.840 |
Why?
| | Organs at Risk | 3 | 2017 | 16 | 0.830 |
Why?
| | Parotid Gland | 2 | 2017 | 17 | 0.800 |
Why?
| | Radiosurgery | 3 | 2020 | 43 | 0.800 |
Why?
| | Organ Sparing Treatments | 2 | 2017 | 11 | 0.800 |
Why?
| | Carcinoma, Squamous Cell | 3 | 2017 | 207 | 0.730 |
Why?
| | Xerostomia | 1 | 2017 | 8 | 0.680 |
Why?
| | Internship and Residency | 1 | 2021 | 201 | 0.680 |
Why?
| | Prostatic Neoplasms | 2 | 2018 | 122 | 0.660 |
Why?
| | Phantoms, Imaging | 5 | 2020 | 44 | 0.610 |
Why?
| | Monte Carlo Method | 5 | 2018 | 56 | 0.560 |
Why?
| | Gamma Rays | 1 | 2015 | 17 | 0.560 |
Why?
| | Limbic System | 2 | 2011 | 12 | 0.540 |
Why?
| | Quality Assurance, Health Care | 1 | 2015 | 54 | 0.540 |
Why?
| | Tomography, Spiral Computed | 2 | 2011 | 27 | 0.510 |
Why?
| | Neural Stem Cells | 1 | 2013 | 17 | 0.490 |
Why?
| | Scattering, Radiation | 4 | 2020 | 42 | 0.480 |
Why?
| | Breast Neoplasms | 6 | 2017 | 442 | 0.410 |
Why?
| | Humans | 31 | 2021 | 31481 | 0.390 |
Why?
| | Uterine Cervical Neoplasms | 3 | 2015 | 53 | 0.370 |
Why?
| | Lung Neoplasms | 5 | 2020 | 756 | 0.360 |
Why?
| | Electrons | 2 | 2009 | 18 | 0.360 |
Why?
| | Computer Simulation | 4 | 2018 | 249 | 0.330 |
Why?
| | Tomography, X-Ray Computed | 6 | 2018 | 891 | 0.330 |
Why?
| | Radiotherapy, Image-Guided | 2 | 2018 | 8 | 0.320 |
Why?
| | Reproducibility of Results | 3 | 2021 | 886 | 0.290 |
Why?
| | Algorithms | 4 | 2018 | 412 | 0.280 |
Why?
| | Rectum | 2 | 2021 | 72 | 0.250 |
Why?
| | Sensitivity and Specificity | 3 | 2015 | 580 | 0.250 |
Why?
| | Feasibility Studies | 4 | 2011 | 281 | 0.240 |
Why?
| | Printing, Three-Dimensional | 1 | 2021 | 5 | 0.230 |
Why?
| | Retroperitoneal Neoplasms | 1 | 2021 | 10 | 0.220 |
Why?
| | Body Burden | 3 | 2013 | 10 | 0.220 |
Why?
| | Vagina | 1 | 2021 | 53 | 0.220 |
Why?
| | Models, Biological | 1 | 2004 | 428 | 0.220 |
Why?
| | Physics | 1 | 2021 | 4 | 0.220 |
Why?
| | Molecular Imaging | 1 | 2020 | 7 | 0.210 |
Why?
| | Female | 14 | 2021 | 18253 | 0.180 |
Why?
| | Sarcoma | 1 | 2021 | 139 | 0.180 |
Why?
| | Proton Therapy | 1 | 2018 | 2 | 0.170 |
Why?
| | Photons | 1 | 2018 | 4 | 0.170 |
Why?
| | Acoustics | 1 | 2018 | 17 | 0.170 |
Why?
| | Relative Biological Effectiveness | 2 | 2010 | 6 | 0.170 |
Why?
| | Intraoperative Care | 1 | 2017 | 58 | 0.170 |
Why?
| | Particle Accelerators | 2 | 2009 | 8 | 0.160 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2021 | 236 | 0.160 |
Why?
| | Male | 10 | 2018 | 17583 | 0.160 |
Why?
| | Prognosis | 2 | 2017 | 1028 | 0.160 |
Why?
| | Liver Neoplasms | 1 | 2018 | 117 | 0.150 |
Why?
| | Radiotherapy, Adjuvant | 3 | 2017 | 84 | 0.150 |
Why?
| | Magnetic Resonance Imaging | 3 | 2011 | 1273 | 0.150 |
Why?
| | Lymphatic Metastasis | 2 | 2014 | 107 | 0.150 |
Why?
| | Radiation Dosage | 1 | 2015 | 35 | 0.140 |
Why?
| | Intestine, Small | 1 | 2015 | 37 | 0.140 |
Why?
| | Mesenchymal Stem Cell Transplantation | 2 | 2006 | 32 | 0.140 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 3 | 2014 | 374 | 0.140 |
Why?
| | Equipment Design | 2 | 2012 | 198 | 0.130 |
Why?
| | Whole-Body Irradiation | 2 | 2012 | 19 | 0.130 |
Why?
| | United States | 1 | 2021 | 2539 | 0.130 |
Why?
| | Chemoradiotherapy | 1 | 2014 | 69 | 0.130 |
Why?
| | Quality of Life | 1 | 2017 | 663 | 0.120 |
Why?
| | Medical Illustration | 1 | 2012 | 20 | 0.120 |
Why?
| | Radiation Oncology | 1 | 2012 | 18 | 0.110 |
Why?
| | Equipment Failure Analysis | 1 | 2012 | 116 | 0.110 |
Why?
| | Radiotherapy, Computer-Assisted | 1 | 2011 | 3 | 0.110 |
Why?
| | Prone Position | 1 | 2011 | 25 | 0.110 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2014 | 405 | 0.100 |
Why?
| | Lymph Nodes | 1 | 2011 | 84 | 0.100 |
Why?
| | Pituitary Gland | 1 | 2010 | 15 | 0.100 |
Why?
| | Dentate Gyrus | 1 | 2010 | 9 | 0.100 |
Why?
| | Lateral Ventricles | 1 | 2010 | 7 | 0.100 |
Why?
| | Brain Stem | 1 | 2010 | 26 | 0.100 |
Why?
| | Pancreatic Neoplasms | 1 | 2012 | 181 | 0.100 |
Why?
| | Computer-Aided Design | 1 | 2009 | 15 | 0.100 |
Why?
| | Larynx | 1 | 2009 | 14 | 0.100 |
Why?
| | Oropharyngeal Neoplasms | 1 | 2009 | 23 | 0.090 |
Why?
| | Heart | 1 | 2009 | 110 | 0.090 |
Why?
| | Radiotherapy | 1 | 2009 | 65 | 0.090 |
Why?
| | Carcinoma | 1 | 2009 | 84 | 0.090 |
Why?
| | Axilla | 1 | 2008 | 17 | 0.090 |
Why?
| | Carcinoma, Ductal, Breast | 1 | 2008 | 36 | 0.090 |
Why?
| | Retrospective Studies | 5 | 2021 | 3591 | 0.080 |
Why?
| | Treatment Outcome | 2 | 2013 | 3910 | 0.080 |
Why?
| | Transplantation, Heterologous | 1 | 2006 | 26 | 0.080 |
Why?
| | Skin Transplantation | 1 | 2006 | 17 | 0.080 |
Why?
| | Bone Marrow Transplantation | 1 | 2006 | 40 | 0.080 |
Why?
| | Graft Rejection | 1 | 2006 | 84 | 0.070 |
Why?
| | Histocompatibility | 1 | 2004 | 5 | 0.070 |
Why?
| | Transplantation Conditioning | 1 | 2004 | 40 | 0.070 |
Why?
| | Adult | 3 | 2013 | 9779 | 0.060 |
Why?
| | Models, Statistical | 1 | 2004 | 144 | 0.060 |
Why?
| | Survival Rate | 2 | 2014 | 465 | 0.060 |
Why?
| | Cognition | 1 | 2010 | 1206 | 0.050 |
Why?
| | Aged | 5 | 2014 | 10295 | 0.050 |
Why?
| | Brain | 1 | 2010 | 1655 | 0.050 |
Why?
| | Middle Aged | 5 | 2014 | 11209 | 0.050 |
Why?
| | Four-Dimensional Computed Tomography | 1 | 2018 | 5 | 0.040 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 28 | 0.040 |
Why?
| | Water | 1 | 2017 | 37 | 0.040 |
Why?
| | Carcinoma, Large Cell | 1 | 2014 | 18 | 0.030 |
Why?
| | Urinary Bladder | 1 | 2013 | 21 | 0.030 |
Why?
| | Decision Support Techniques | 1 | 2013 | 55 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2014 | 456 | 0.030 |
Why?
| | Celiac Artery | 1 | 2012 | 2 | 0.030 |
Why?
| | Pancreaticojejunostomy | 1 | 2012 | 3 | 0.030 |
Why?
| | Mesenteric Artery, Superior | 1 | 2012 | 5 | 0.030 |
Why?
| | Radiography, Abdominal | 1 | 2012 | 7 | 0.030 |
Why?
| | Aortography | 1 | 2012 | 14 | 0.030 |
Why?
| | Anatomic Landmarks | 1 | 2012 | 8 | 0.030 |
Why?
| | Tumor Burden | 1 | 2012 | 42 | 0.030 |
Why?
| | Neoplasm Staging | 1 | 2014 | 481 | 0.030 |
Why?
| | Adenocarcinoma | 1 | 2014 | 237 | 0.030 |
Why?
| | Portal Vein | 1 | 2012 | 47 | 0.030 |
Why?
| | Consensus | 1 | 2012 | 106 | 0.030 |
Why?
| | Supine Position | 1 | 2011 | 18 | 0.030 |
Why?
| | X-Ray Film | 1 | 2011 | 3 | 0.030 |
Why?
| | Artifacts | 1 | 2011 | 35 | 0.030 |
Why?
| | Software | 1 | 2011 | 74 | 0.030 |
Why?
| | Lung | 1 | 2011 | 171 | 0.030 |
Why?
| | Small Cell Lung Carcinoma | 1 | 2010 | 13 | 0.020 |
Why?
| | Calibration | 1 | 2009 | 25 | 0.020 |
Why?
| | Radiographic Image Enhancement | 1 | 2009 | 16 | 0.020 |
Why?
| | Radiation Protection | 1 | 2009 | 8 | 0.020 |
Why?
| | Metals | 1 | 2011 | 157 | 0.020 |
Why?
| | Imaging, Three-Dimensional | 1 | 2011 | 233 | 0.020 |
Why?
| | Models, Anatomic | 1 | 2009 | 68 | 0.020 |
Why?
| | Iridium Radioisotopes | 1 | 2008 | 7 | 0.020 |
Why?
| | Heart Ventricles | 1 | 2009 | 218 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2014 | 2028 | 0.020 |
Why?
| | Mastectomy, Segmental | 1 | 2008 | 34 | 0.020 |
Why?
| | Treatment Failure | 1 | 2008 | 187 | 0.020 |
Why?
| | Radiography | 1 | 2009 | 717 | 0.020 |
Why?
| | Incidence | 1 | 2010 | 829 | 0.020 |
Why?
| | Rats, Inbred ACI | 1 | 2006 | 1 | 0.020 |
Why?
| | Chimerism | 1 | 2006 | 4 | 0.020 |
Why?
| | Killer Cells, Natural | 1 | 2006 | 93 | 0.020 |
Why?
| | Animals | 2 | 2006 | 5312 | 0.020 |
Why?
| | Hemibody Irradiation | 1 | 2004 | 4 | 0.020 |
Why?
| | beta-Galactosidase | 1 | 2004 | 9 | 0.020 |
Why?
| | Papio | 1 | 2004 | 12 | 0.020 |
Why?
| | Transduction, Genetic | 1 | 2004 | 22 | 0.020 |
Why?
| | Animals, Genetically Modified | 1 | 2004 | 18 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2006 | 548 | 0.020 |
Why?
| | Genes, Reporter | 1 | 2004 | 32 | 0.020 |
Why?
| | Injections | 1 | 2004 | 59 | 0.020 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2004 | 40 | 0.020 |
Why?
| | Stromal Cells | 1 | 2004 | 39 | 0.020 |
Why?
| | Rats | 1 | 2006 | 966 | 0.020 |
Why?
| | Graft Survival | 1 | 2004 | 111 | 0.020 |
Why?
| | Transplantation, Homologous | 1 | 2004 | 292 | 0.020 |
Why?
| | Mice | 1 | 2006 | 1894 | 0.010 |
Why?
|
|
Turian's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|